Related references
Note: Only part of the references are listed.CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitides
Lucy McGeoch et al.
JOURNAL OF RHEUMATOLOGY (2016)
Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis A Randomized Clinical Trial
Claus Bachert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Reductions in eosinophil biomarkers by benralizumab in patients with asthma
Tuyet-Hang Pham et al.
RESPIRATORY MEDICINE (2016)
Long-Term Followup of a Multicenter Cohort of 101 Patients With Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)
Cecile-Audrey Durel et al.
ARTHRITIS CARE & RESEARCH (2016)
Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides A French Nationwide Study of Ninety-Two Patients
Etienne Crickx et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
A. J. Mohammad et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Impact of cardiac magnetic resonance imaging on eosinophilic granulomatosis with polyangiitis outcomes: A long-term retrospective study on 42 patients
Bertrand Dunogue et al.
AUTOIMMUNITY REVIEWS (2015)
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management
Matthieu Groh et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2015)
Update on reslizumab for eosinophilic asthma
Juan Carlos Cardet et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Randomized trial investigating the safety and efficacy of influenza vaccination in patients with antineutrophil cytoplasmic antibody-associated vasculitis
Lisa S. Jeffs et al.
NEPHROLOGY (2015)
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
Nicola A. Hanania et al.
THORAX (2015)
Linking classification and therapeutic management of vasculitides
Corisande Baldwin et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Treatment of Systemic Necrotizing Vasculitides in Patients Aged Sixty-Five Years or Older
Christian Pagnoux et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
Mario Castro et al.
LANCET RESPIRATORY MEDICINE (2015)
Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial
Christopher E. Brightling et al.
LANCET RESPIRATORY MEDICINE (2015)
Noncorticosteroid Immunosuppression Limits Myocardial Damage and Contractile Dysfunction in Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss Syndrome)
Tomasz Miszalski-Jamka et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Mononeuritis multiplex predicts the need for immunosuppressive or immunomodulatory drugs for EGPA, PAN and MPA patients without poor-prognosis factors
Maxime Samson et al.
AUTOIMMUNITY REVIEWS (2014)
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Lorry G. Rubin et al.
CLINICAL INFECTIOUS DISEASES (2014)
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): evolutions in classification, etiopathogenesis, assessment and management
Alfred Mahr et al.
CURRENT OPINION IN RHEUMATOLOGY (2014)
Heart transplantation in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)
Matthieu Groh et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2014)
Churg–Strauss syndrome associated with elevated levels of serum interleukin-5 and T cell receptor-Cβgene rearrangement
Yoshiro Horai et al.
Modern Rheumatology (2014)
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
Elisabeth H. Bel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Hector G. Ortega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Efficacy of imatinib mesylate in a case of Churg-Strauss syndrome: evidence for the pathogenic role of a tyrosine kinase?
Laurence Josselin-Mahr et al.
RHEUMATOLOGY (2014)
Clinical features and prognostic factors of Churg-Strauss syndrome
Mi-Yeong Kim et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2014)
Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study
Christopher E. Brightling et al.
LANCET RESPIRATORY MEDICINE (2014)
Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study
Mario Castro et al.
LANCET RESPIRATORY MEDICINE (2014)
Exploring the Effects of Omalizumab in Allergic Asthma An Analysis of Biomarkers in the EXTRA Study
Nicola A. Hanania et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients
Frank Moosig et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
J. C. Jennette et al.
ARTHRITIS AND RHEUMATISM (2013)
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort
Cloe Comarmond et al.
ARTHRITIS AND RHEUMATISM (2013)
A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma
Edward Piper et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression of Churg-Strauss syndrome
Bridget Healy et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes
Florence E. Roufosse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma
Philippe Gevaert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials
Maxime Samson et al.
JOURNAL OF AUTOIMMUNITY (2013)
Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
Sally Wenzel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Churg-Strauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography: a prospective study on 20 patients
Julien Marmursztejn et al.
RHEUMATOLOGY (2013)
Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)
Jens Thiel et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Serum biomarkers are similar in Churg-Strauss syndrome and hypereosinophilic syndrome
P. Khoury et al.
ALLERGY (2012)
Reslizumab in children and adolescents with eosinophilic esophagitis: Results of a double-blind, randomized, placebo-controlled trial
Jonathan M. Spergel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes
Peter Valent et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Protective effect of A/H1N1 vaccination in immune-mediated disease-a prospectively controlled vaccination study
Sabine Adler et al.
RHEUMATOLOGY (2012)
Targeting Interleukin-5 in Refractory and Relapsing Churg-Strauss Syndrome
Frank Moosig et al.
ANNALS OF INTERNAL MEDICINE (2011)
Rituximab for the treatment of Churg-Strauss syndrome with renal involvement
Rodrigo Cartin-Ceba et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
The Five-Factor Score Revisited Assessment of Prognoses of Systemic Necrotizing Vasculitides Based on the French Vasculitis Study Group (FVSG) Cohort
Loic Guillevin et al.
MEDICINE (2011)
Lebrikizumab Treatment in Adults with Asthma
Jonathan Corren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Alveolar Hemorrhage in Vasculitis: Primary and Secondary
Jean-Francois Cordier et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Efficacy of omalizumab in the treatment of nasal polyps
Maria del Carmen Vennera et al.
THORAX (2011)
Churg-Strauss syndrome: evidence for disease subtypes?
Christian Pagnoux et al.
CURRENT OPINION IN RHEUMATOLOGY (2010)
Sustained response to mepolizumab in refractory Churg-Strauss syndrome
Jean-Emmanuel Kahn et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome
Sophia Kim et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Severe bronchospasm associated with rituximab for refractory Churg-Strauss syndrome
M. -A Bouldouyre et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
A Multicenter Survey of Rituximab Therapy for Refractory Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Rachel B. Jones et al.
ARTHRITIS AND RHEUMATISM (2009)
Churg-Strauss Syndrome in Patients Treated With Omalizumab
Michael E. Wechsler et al.
CHEST (2009)
Omalizumab administration in Churg–Strauss syndrome
Pedro Giavina-Bianchi et al.
European Journal of Internal Medicine (2009)
ANCA-Associated Vasculitis Following Influenza Vaccination Causal Association or Mere Coincidence?
Rainer Birck et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2009)
Hydroxyurea in the treatment of Churg-Strauss syndrome
Rachel U. Lee et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa
Aladdin J. Mohammad et al.
RHEUMATOLOGY (2009)
Treatment of Churg-Strauss syndrome without poor-prognosis factors
Camillo Ribi et al.
ARTHRITIS AND RHEUMATISM (2008)
Magnetic resonance assessment and therapy monitoring of cardiac involvement in Churg-Strauss syndrome
Hannibal Baccouche et al.
CIRCULATION (2008)
Churg-Strauss syndrome associated with omalizumab
Xavier Puechal et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2008)
One year administration of Anti-IgE to a patient with Churg-Strauss syndrome
Pedro Giavina-Bianchi et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2008)
Development of Churg-Strauss syndrome with controlled asthma during omalizumab treatment
Anne-Alarie Ruppert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Omalizumab and Churg-Strauss syndrome
Pedro Giavina-Bianchi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Nasal Polyposis in Churg-Strauss Syndrome
Andrea Bacciu et al.
LARYNGOSCOPE (2008)
Treatment of patients with the hypereosinophilic syndrome with mepolizumab
Marc E. Rothenberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production
R. J. Pepper et al.
RHEUMATOLOGY (2008)
Apparent response to anti-IgE therapy in two patients with refractory forme fruste'' of Churg-Strauss syndrome
S. Pabst et al.
THORAX (2008)
The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case crossover study
T. Hauser et al.
THORAX (2008)
Churg-Strauss Syndrome in the Pediatric Age Group
Yehia El-Gamal
WORLD ALLERGY ORGANIZATION JOURNAL (2008)
Lymphocytic variant hypereosinophilic syndromes
Florence Roufosse et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2007)
Churg-Strauss syndrome with poor-prognosis factors:: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients
Pascal Cohen et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Churg-Strauss syndrome
Christian Pagnoux et al.
CURRENT OPINION IN RHEUMATOLOGY (2007)
Leucoencephalopathy after treatment of Churg-Strauss syndrome with interferon α
C Metzler et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
How can patient care be improved beyond medical treatment?
C Pagnoux et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2005)
Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome
RA Sinico et al.
ARTHRITIS AND RHEUMATISM (2005)
The use of infliximab in a patient with steroid-dependent Churg-Strauss syndrome
A Tiliakos et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2004)
Churg-Strauss syndrome: successful treatment with mycophenolate mofetil
C Assaf et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Relationship between idiopathic hypereosinophilic syndrome, eosinophilic leukemia, and systemic mastocytosis
BJ Bain
AMERICAN JOURNAL OF HEMATOLOGY (2004)
Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome
MG Danieli et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Churg-Strauss syndrome: Clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists
KA Keogh et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Indications of plasma exchanges for systemic vasculitides
L Guillevin et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2003)
Treatment of refractory Churg-Strauss-Syndrome (CSS) by TNF-α blockade
O Arbach et al.
IMMUNOBIOLOGY (2002)
Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma
ME Wechsler et al.
CHEST (2000)
Share Paper
